Ironwood Pharmaceuticals, Inc. (IRWD) financial statements (2022 and earlier)

Company profile

Business Address 100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments363177173221305439248
Cash and cash equivalents3631771731265426174
Short-term investments   96251178174
Restricted cash and investments211    
Receivables1221178182655526
Inventory, net of allowances, customer advances and progress billings 1 11 5
Inventory 1 11 5
Other undisclosed current assets9111179611
Total current assets:496307266312380500290
Noncurrent Assets
Operating lease, right-of-use asset1718✕✕✕✕✕
Property, plant and equipment9121717212130
Long-term investments and receivables2333     
Accounts and financing receivable, after allowance for credit loss2333     
Intangible assets, net (including goodwill) 11161167  
Goodwill 1111  
Intangible assets, net (excluding goodwill)   160166  
Derivative instruments and hedges13314110813386 
Restricted cash and investments016 898
Other noncurrent assets1001136
Other undisclosed noncurrent assets   7   
Total noncurrent assets:63966629433011944
TOTAL ASSETS:559403332606710619334
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18346054563250
Accounts payable14181618910
Accrued liabilities3111513382323
Employee-related liabilities13192624  17
Interest and dividends payable2011  1
Deferred revenue 1✕✕✕✕✕
Debt 148462812
Deferred rent credit  0✕✕✕✕
Restructuring reserve1103    
Due to related parties 2  000
Business combination, contingent consideration, liability  0014  
Deferred revenue and credits✕✕✕081312
Other undisclosed current liabilities338774(14)
Total current liabilities:324112066917661
Noncurrent Liabilities
Long-term debt and lease obligation451430366 132133165
Long-term debt, excluding current maturities430408366 132133162
Capital lease obligations✕✕0 003
Operating lease, liability2022✕✕✕✕✕
Liabilities, other than long-term debt1425431341859420
Deferred revenue and credits✕✕✕51820
Deferred rent credit  6✕✕✕✕
Other liabilities2135810 
Business combination, contingent consideration, liability   3163  
Derivative instruments and hedges, liabilities1224349211375 
Total noncurrent liabilities:464455409134318227184
Total liabilities:497496528200409303245
Stockholders' equity
Stockholders' equity attributable to parent, including:63(93)(196)10679589
Common stock00     
Additional paid in capital1,5291,4791,3951,3191,2581,2051,056
Accumulated other comprehensive loss   (0)(0)(0)(0)
Accumulated deficit(1,466)(1,572)(1,591)(1,309)(1,192)(1,110)(967)
Other undisclosed stockholders' equity attributable to parent  00000
Total stockholders' equity:63(93)(196)10679589
Other undisclosed liabilities and equity   396234221 
TOTAL LIABILITIES AND EQUITY:559403332606710619334

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues39042834729827415076
Cost of revenue(3)(24)(33)(19)(2)(0)(26)
Cost of goods and services sold(3)(24)(33) (0)(18)(20)
Gross profit:38640531427927215051
Operating expenses(243)(291)(584)(388)(314)(234)(221)
Other undisclosed operating income (loss) 73131(10)(18)1
Operating income (loss):143120(239)(77)(52)(102)(169)
Nonoperating expense(34)(61)(43)(40)(30)(41)(20)
Investment income, nonoperating(5)6(6)(1)9(9)0
Interest and debt expense(29)(31)(38)(2)(39)(31)(21)
Income (loss) from continuing operations before equity method investments, income taxes:7928(320)(119)(121)(174)(211)
Other undisclosed income from continuing operations before income taxes29      
Income (loss) from continuing operations before income taxes:10928(320)(119)(121)(174)(211)
Income tax expense(3)      
Other undisclosed income from continuing operations 31     
Income (loss) from continuing operations:10659(320)(119)(121)(174)(211)
Loss from discontinued operations (37)     
Income (loss) before gain (loss) on sale of properties:10622(320)(119)(121)(174)(211)
Other undisclosed net income  382   
Net income (loss) attributable to parent:10622(282)(117)(121)(174)(211)
Other undisclosed net income available to common stockholders, basic    393121
Net income (loss) available to common stockholders, diluted:10622(282)(117)(82)(143)(190)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):10622(282)(117)(121)(174)(211)
Comprehensive income (loss):10622(282)(117)(121)(174)(211)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  0(0)393121
Comprehensive income (loss), net of tax, attributable to parent:10622(282)(117)(82)(143)(190)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: